In our study, mesothelin expression and co-expression of mesothelin and CA125 were more often observed in patients with other histological types – including serous carcinoma, clear cell carcinoma, and carcinosarcoma –mixed carcinoma, and associated deeper myometrial invasion and lymphovascular invasion. The gene discussed is MUC16; the disease is clear cell adenocarcinoma.